Peptide-Based Ehrlichia Species Identification Assay
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current assays for detecting Ehrlichia bacteria species, such as E. canis, E. chaffeensis, and E. ewingii, face challenges due to sensitivity and specificity issues related to impure antigens, requiring complex methods like PCR or tissue cultivation, which are not practical for all circumstances, especially for identifying E. ewingii which lacks a cultivation method.
Innovation Solution
The use of specific peptide mixtures or populations that have preferential binding affinity for antibodies elicited by Ehrlichia species, allowing for the identification of infecting species through antibody-peptide complex formation in a sample, using methods like ELISA or lateral flow assays.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If PCR methods are used to identify Ehrlichia species, then species identification accuracy is improved, but the requirement for freshly infected tissue and complex procedures worsen practical applicability
Solution Approach 1:
The patent extracts and isolates specific peptide sequences from Ehrlichia antigens that are species-specific. By using purified peptides instead of whole antigens or complex PCR methods, the invention simplifies the diagnostic process while maintaining species identification accuracy. The peptides can be detected in dried blood spots or serum samples without requiring freshly infected tissue.
Solution Approach 2:
The patent creates simplified copies of the diagnostic function by using peptide-based immunoassays that replicate the species-specific detection capability of PCR methods. These peptide assays can be performed on stable, dried samples rather than requiring fresh tissue, making the diagnostic function accessible in various settings.
2Loss of information
If tissue cultivation methods are used to identify Ehrlichia species, then diagnostic information is improved, but the technical complexity and requirement for freshly infected tissue worsen ease of operation
Solution Approach 1:
The patent extracts essential diagnostic information by identifying and isolating specific peptide sequences that are unique to different Ehrlichia species. This extraction approach captures the key diagnostic features without requiring complex tissue cultivation procedures, enabling species identification from simpler samples like dried blood spots.
Solution Approach 2:
The patent performs preliminary action by pre-identifying and characterizing species-specific peptide sequences from Ehrlichia antigens. These characterized peptides are then used as diagnostic reagents that can directly detect species-specific antibodies in patient samples, eliminating the need for time-consuming tissue cultivation and complex diagnostic procedures.
3Reliability
If mixtures of whole Ehrlichia antigens are used in immunoassays, then antibody detection capability is improved, but species-specific identification accuracy worsens due to impurity
Solution Approach 1:
The patent segments whole Ehrlichia antigens into individual peptide sequences, identifying those that are species-specific. By using segmented peptides rather than whole antigen mixtures, the invention achieves both reliable antibody detection and accurate species identification. Each peptide can be independently tested for its ability to detect species-specific antibodies.
Solution Approach 2:
The patent applies local quality by selecting peptides with specific properties that are unique to certain Ehrlichia species. Rather than using uniform whole antigens, the invention uses locally optimized peptide sequences that have high specificity for particular species, improving identification accuracy while maintaining detection capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables accurate identification of Ehrlichia species in various samples without the need for freshly infected tissues, improving diagnostic efficiency and specificity, particularly for E. ewingii, which lacks a cultivation method.
Implementation Method 1
particular mixtures, or populations, of Ehrlichia peptides or their variants have preferential binding affinity for antibodies elicited by antigens from particular Ehrlichia species
Data Source
AI summary
The invention provides methods, kits, compositions, and devices useful for detection of antibodies that bind to Ehrlichia antigens and/or for differentiation of certain Ehrlichia species from others. In particular, the invention provides methods and kits useful for identifying species of Ehrlichia using populations of isolated peptides.